Filtered By:
Vaccination: Influenza Vaccine

This page shows you your search results in order of date. This is page number 11.

Order by Relevance | Date

Total 1458 results found since Jan 2013.

International Travel Vaccine Recommendations for Children
This article (1) explores the universally recommended routine vaccines that are particularly important for children to be up to date before travel (ie, measles, mumps, rubella; hepatitis A and B; polio; meningococcal; coronavirus disease 2019 [COVID-19]; and influenza) and (2) explains the travel-specific vaccination recommendations (ie, dengue, cholera, typhoid, tick-borne encephalitis, yellow fever, Japanese encephalitis, and rabies). Physicians can encourage parents to consult the Centers for Disease Control and Prevention website for travel vaccine recommendations (https://wwwnc.cdc.gov/travel). Children must remain up...
Source: Pediatric Annals - March 7, 2023 Category: Pediatrics Authors: Maria Fernanda Machicao Sarah Yashar-Gershman Jos é R Romero Henry H Bernstein Source Type: research

Myocarditis update from Sweden
BY ANISH KOKA The COVID19/vaccine myocarditis debate continues in large part because our public health institutions are grossly mischaracterizing the risks and benefits of vaccines to young people. A snapshot of what the establishment says as it relates to the particular area of concern: college vaccine mandates: Dr. Arthur Reingold, an epidemiology professor at UC-Berkeley, notes that UC also requires immunizations for measles and chickenpox, and people still are dying from COVID at rates that exceed those for influenza. As of Feb. 1, there were more than 400 COVID deaths a day across the U.S. “The arg...
Source: The Health Care Blog - February 27, 2023 Category: Consumer Health News Authors: Ryan Bose-Roy Tags: Medical Practice Anish Koka covid19 myocarditis Sweden Source Type: blogs

Bidirectional and persistent immunomodulation of Astragalus polysaccharide as an adjuvant of influenza and recombinant SARS-CoV-2 vaccine
Int J Biol Macromol. 2023 Feb 15:123635. doi: 10.1016/j.ijbiomac.2023.123635. Online ahead of print.ABSTRACTRespiratory viral infections, such as coronavirus disease of 2019 (COVID-19) and influenza, cause significant morbidity and mortality and have become a worldwide public health concern with tremendous economic and societal burdens. Vaccination is a major strategy for preventing infections. However, some new vaccines have an unmet need for impairing responses in certain individuals, especially COVID-19 vaccines, despite ongoing vaccine and adjuvant research. Here, we evaluated the effectiveness of Astragalus polysaccha...
Source: International Journal of Biological Macromolecules - February 21, 2023 Category: Biochemistry Authors: Danping Zhao Xiuhong Chen Linyuan Wang Jianjun Zhang Zhongpeng Zhao Na Yue Yingli Zhu Wenting Fei Xinyu Li Lingyun Tan Wei He Source Type: research

TWiV 984: Clinical update with Dr. Daniel Griffin
In his weekly clinical update Dr. Griffin discusses the political polarization of COVID-19 treatments among physicians and laypeople in the United States, seven alternatives to evidence-based medicine, Malawi’s cholera death toll crosses 1,300 in its deadliest outbreak on record, impact of coronavirus infections on pediatric patients at a tertiary pediatric hospital, maternal mRNA COVID-19 vaccination during […]
Source: virology blog - February 18, 2023 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology antiviral coronavirus COVID-19 delta inflammation influenza Long Covid monkeypox monoclonal antibody Omicron pandemic poliovirus SARS-CoV-2 vaccine vaccine booster variant of concern viruses Source Type: blogs

Coronavirus tally: Moderna flu vaccine trial falls short on one goal, sending stock down
Moderna Inc. MRNA, stock was down 6.6% premarket Friday, after the COVID vaccine maker said a trial of a flu vaccine candidate failed to meet one of its goals. "While we did not achieve non-inferiority for the Influenza B strains which are more frequent in younger populations, we have already…#modernaincmrna #stephenhoge
Source: Reuters: Health - February 17, 2023 Category: Consumer Health News Source Type: news

Analysis of hematologic adverse events reported to a national surveillance system following COVID-19 bivalent booster vaccination
AbstractHematologic complications, including vaccine-induced immune thrombotic thrombocytopenia (VITT), immune thrombocytopenia (ITP), and autoimmune hemolytic anemia (AIHA), have been associated with the original severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines. However, on August 31, 2022, new formulations of the Pfizer-BioNTech and Moderna vaccines were approved for use without clinical trial testing. Thus, any potential adverse hematologic effects with these new vaccines remain unknown. We queried the US Centers for Disease Control Vaccine Adverse Event Reporting System (VAERS), a national surveill...
Source: Annals of Hematology - February 16, 2023 Category: Hematology Source Type: research

Effects of a video-based positive side-effect information framing: An online experiment.
Conclusions: Facing the ongoing coronavirus mass vaccinations, positive information frames have a small but significant impact on vaccination concerns while upholding informed consent. Although intervention trials are still pending, this approach could help decrease vaccine hesitancy by reducing fearful expectations. However, it seems that it should not be used without considering vaccination attitudes. (PsycInfo Database Record (c) 2023 APA, all rights reserved)
Source: Health Psychology - February 13, 2023 Category: Psychiatry & Psychology Source Type: research

Japan moves to bolster vaccine R & D after COVID-19 exposed startling weakness
The COVID-19 pandemic exposed the feeble state of Japan’s vaccine research and development capabilities. Only now, for example, are Japanese regulators considering approval of the country’s first homegrown COVID-19 vaccines, months after many less advanced nations developed their own shots. Determined to catch up, Japan is ramping up a 1.1 trillion yen ($8.5 billion) initiative that aims to give Japan the capability to develop a vaccine for a new virus in 100 days, a goal being adopted by many countries. That “very ambitious” push “is definitely a welcome development,” especially given that it will give ne...
Source: Science of Aging Knowledge Environment - February 9, 2023 Category: Geriatrics Source Type: research

Convalescent Plasma Therapy against COVID-19: An update on the changing facets of the ongoing Pandemic
This article aimed to present an up-to-date evaluation of existing literature on the efficacy of convalescent plasma as a potential therapy, its safety and effectiveness and the challenges in treating COVID-19.PMID:36733203 | DOI:10.2174/1389201024666230202144314
Source: Current Pharmaceutical Biotechnology - February 3, 2023 Category: Biotechnology Authors: Saquib Shahabe Abullais Suraj Arora Shadma Wahab Vishakha Grover Mohammed Yahya Al-Shahrani Shaik Mohamed Shamsudeen Shaik Mohammed Asif Amel Ibrahim Faragalla Mohamed Fadul A Elgib Source Type: research

Recommendations for modernizing infant vaccination schedules with combination vaccines in Colombia and Peru
The objective of this article was to consider the vaccination challenges in Colombia and Peru and the role of pediatric combination vaccines in overcoming these challenges. Barriers to including new vaccines with more antigens remain apparent in parts of these countries, where vaccine-preventable diseases in infants continue to be a major problem. The challenges include the heterogeneity of vaccine coverage within each country and in neighboring countries, which can contribute to poor rates of vaccination coverage; the adverse impact of the inward migration of unvaccinated individuals, which has favored the re-emergence of...
Source: Pan American Journal of Public Health - February 2, 2023 Category: International Medicine & Public Health Authors: Carlos Torres-Martinez Eduardo Chaparro Ana-Cristina Mari ño Luiza Helena Falleiros-Arlant Germ án Camacho-Moreno Mar ía E Castillo Carlos Garces Wilfrido Coronell Roberto Somocurcio Source Type: research